Litigation Details for ACADIA Pharmaceuticals Inc. v. Aurobindo Pharma Limited (D. Del. 2022)
✉ Email this page to a colleague
ACADIA Pharmaceuticals Inc. v. Aurobindo Pharma Limited (D. Del. 2022)
| Docket | ⤷ Try a Trial | Date Filed | 2022-10-21 |
| Court | District Court, D. Delaware | Date Terminated | |
| Cause | 35:271 Patent Infringement | Assigned To | Gregory B. Williams |
| Jury Demand | None | Referred To | |
| Parties | ACADIA PHARMACEUTICALS INC.; AUROBINDO PHARMA USA, INC. | ||
| Patents | 10,028,944; 10,449,185; 10,517,860; 6,756,393; 6,815,458; 7,115,634; 7,601,740; 7,659,285; 7,732,615; 7,816,383; 7,858,789; 7,863,296; 7,923,564; 8,110,574; 8,618,130; 8,921,393; 9,296,694; 9,566,271; 9,765,053 | ||
| Attorneys | Chad J. Peterman; R. Touhey Myer; Shashank D. Upadhye | ||
| Firms | Kratz & Barry LLP; Saul Ewing Arnstein & Lehr LLP | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in ACADIA Pharmaceuticals Inc. v. Aurobindo Pharma Limited
The small molecule drugs covered by the patents cited in this case are ⤷ Try a Trial and ⤷ Try a Trial .
Biologic Drugs cited in ACADIA Pharmaceuticals Inc. v. Aurobindo Pharma Limited
The biologic drug covered by the patents cited in this case is ⤷ Try a Trial .
Details for ACADIA Pharmaceuticals Inc. v. Aurobindo Pharma Limited (D. Del. 2022)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2022-10-21 | 1 | Exhibit A | 2022/0000852 A1 1/2022 Burstein 10,028,944 B2 7/2018 Weiner et al . … filed Jan. 3 , 2017 , U.S. Pat. No. 10,028,944 . WO WO - 06104826 A2 10/2006… Patent ( 10) Patent No .: US 11,452,721… COMPLAINT for PATENT INFRINGEMENT filed against Aurobindo Pharma Limited and Aurobindo Pharma USA… (45) Date of Patent : * Sep . 27, 2022 ( 54 ) FORMULATIONS OF PIMAVANSERIN | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
